The average Royalty Pharma plc - Ordinary Shares - Class A dividend yield over the last 5 years is 2.23% and the average over the last 10 years is 1.17%.

The payout ratio of Royalty Pharma plc - Ordinary Shares - Class A in relation to the last financial year is 64.71%. The payout ratio smoothed over 3 years is 53.85%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).

On the stock exchange, the Royalty Pharma plc - Ordinary Shares - Class A stock (ISIN: GB00BMVP7Y09) is not traded as a top scorer in September 2026 according to the dividend strategy.

The stock price of Royalty Pharma plc - Ordinary Shares - Class A 50.65% has risen since the beginning of the year 2026. However, the return generated in the past says nothing about the future return. You can find the Royalty Pharma plc - Ordinary Shares - Class A stock price in real time at the top of the page.

Royalty Pharma plc - Ordinary Shares - Class A (symbol: RPRX) is valued at a Price / Earnings Ratio (P/E ratio) of 39.92 and a price/sales ratio (P/S ratio) of 13.22 valued. Based on analyst estimates, the Royalty Pharma plc - Ordinary Shares - Class A stock forecast 2026 of the current financial year corresponds to a valuation of 10.88 according to P/E ratio and 9.85 according to P/S.

Royalty Pharma plc - Ordinary Shares - Class A (symbol: RPRX) is valued at a Price / Earnings Ratio (P/E ratio) of 39.92 and a price/sales ratio (P/S ratio) of 13.22 valued. Based on analyst estimates, the Royalty Pharma plc - Ordinary Shares - Class A stock forecast 2026 of the current financial year corresponds to a valuation of 10.88 according to P/E ratio and 9.85 according to P/S.